Abstract:Background: High fasting plasma glucose (HFPG) is the fastest-growing risk factor for cancer deaths worldwide. We reported the cancer burden attributed to HFPG in a total of 204 countries and territories over the past three decades and associations with age, period, and birth cohort. Furthermore, we investigated the association between glycemic levels and all-cause mortality in cancer survivors.Methods: The estimated data on cancer burden attributable to HFPG were retrieved from the Global Burden of Disease Study 2019. The net drift, as well as the effects of age, period, and birth cohort, were assessed by the age-period-cohort model. Data for the association between glycemic levels and mortality were obtained from the 1999-2018 National Health and Nutrition Examination Survey (NHANES). Cox proportional hazard and restricted cubic spline regression models were performed to evaluate the associations between haemoglobin A1c (HbA1c) and all-cause mortality in cancer survivors.Findings: Over the past 30 years, the global age-standardized mortality rate (ASMR) attributable to HFPG has been increased by 27.8%. The ASMR in 2019 was highest in the male population in high sociodemographic index (SDI) areas (8.70; 95% CI, 2.23-18.04). The net drift for mortality was highest in the female population in low SDI areas (2.33; 95% CI, 2.21-2.44). Unfavorable period and cohort effects were found across most countries. The trend of disability-adjusted life years (DALYs) was similar to that of mortality. In NHANES, after adjusting for confounders, HbA1c had independent nonlinear association with increased all-cause mortality in cancer survivors (nonlinear P value = 0.034). The threshold value for HbA1c was 5.4%, and the HRs (95% CI) below and above the threshold value were 0.93 (0.87, 0.99) and 1.03 (1.01, 1.05), respectively.Interpretation: The cancer mortality and DALYs attributed to HFPG have upsurged during the past three decades. In addition, it was found that countries with a higher SDI have a higher age-standardized mortality as well as DALYs, countries with a lower SDI have a larger increase rate. Unfavorable period and cohort effects on mortality and DALYs were seen across almost all countries with different SDI levels. Furthermore, it was suggested that the critical value of HbA1c in decreased mortality was 5.4%, which may prevent premature death in cancer survivors.Funding: This research was funded by the industry prospecting and common key technology key projects of Jiangsu Province Science and Technology Department (Grant no. BE2020721); Nanjing Life and Health Technology Special Project "Cooperative research, development and transformation of active intelligent health management platform for diabetes mellitus" (202205053); the Industrial and Information Industry Transformation and Upgrading Special Fund of Jiangsu Province in 2021 (Grant no. [2021]92)); the Key Project of Smart Jiangsu in 2020 (Grant no. [2021]1); Jiangsu Province Engineering Research Center of Big Data Application in Chronic Disease and Intelligent Health Service (Grant no. [2020]1460).Declaration of Interest: The authors declare that they have no conflict of interest.Ethical Approval: The studies involving human participants were reviewed and approved by the National Center for Health Statistics of the Center for Disease Control and Prevention Institutional Review Board. The patients/participants provided their written informed consent to participate in this study.

Global Burden of Alzheimer’s Disease and Other Dementias Attributed to High Fasting Plasma Glucose from 1990 to 2019

The Global Burden of Ischemic Heart Disease Attributed to High Fasting Plasma Glucose: Data from 1990 to 2019

The burden of cardiovascular disease attributable to high fasting plasma glucose：Findings from the global burden of disease study 2019

Global Burden of Noncommunicable Diseases Attributable to High Fasting Plasma Glucose.

Alzheimer’s Disease and Other Dementias in China: Secular Trend in Disease Burden from 1990 to 2019 and Projections to 2030

Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019

Trends in Prevalence and Disability-Adjusted Life-Years of Alzheimer's Disease and Other Dementias in China from 1990 to 2019.

Global Burden and Drivers of Hyperglycemia: Estimates and Predictions from 1990 to 2050

Disparities by region, age, and sex in cardiovascular disease burden attributable to high fasting plasma glucose in China, 2010-2018: a nationwide, population-based study

Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019

Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019

Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019

Global, Regional, and National Time Trends in Cancer Burden Attributed to High Fasting Plasma Glucose and the Association Between Glycemic Levels and All-Cause Mortality in Cancer Survivors: an Age-Period Cohort Analysis and A Retrospective Cohort Study

Temporal trends of ischemic stroke attributable to high fasting plasma glucose in China from the global burden of disease study 2019

Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021

Disparities in high fasting plasma glucose-related cardiovascular disease burden in China

Disease Burden and Attributable Risk Factors of Alzheimer’s Disease and Dementia in China from 1990 to 2019

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019

Temporal trend and attributable risk factors of Alzheimer's disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021

Temporal trends in the visual impairment burden attributable to high fasting plasma glucose levels: a population-based study

Time trends in Alzheimer's disease mortality attributable to metabolic risks and smoking in China from 1990 to 2019: an age-period-cohort analysis